Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings
Biomet Manufacturing Corp · Decision date Sep 1, 2026
What did the FDA decide?
The FDA record for P010014/S118, dated 2026-09-01, describes a 30-Day Notice for a process change in the manufacturer, sterilizer, packager or supplier category. The reported change is an additional supplier of tantalum balls used during manufacturing of Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings at the Zimmer Inc., Warsaw, Indiana facility. The device category listed is a semi-constrained, metal/polymer, mobile-bearing unicompartmental femorotibial knee prosthesis (product code NRA), with Biomet Manufacturing Corp as applicant.
Read as a supplement to PMA P010014, this notice concerns a manufacturing input and does not represent a new approval of the whole knee system or an original PMA. The source states the supplier addition as its reported purpose; the record does not establish independent proof of safety or clinical effectiveness, and it gives no detail on the tantalum balls' specifications, qualification testing or supplier identity.
FDA approval order statement
an additional supplier of tantalum balls used during manufacturing of Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings at the Zimmer Inc., Warsaw, Indiana facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 1, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P010014/S118
- Regulatory pathway
- PMA supplement
- Applicant
- Biomet Manufacturing Corp
- Product code
- NRA
- Decision code
- OK30
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Biomet Manufacturing Corp
- Product code
- NRA
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.
FDA decision timeline
P010014 · Original PMA
OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
P010014/S118 received
Application receipt date recorded by FDA.
P010014/S118 · FDA decision
30-Day Notice
P010014/S119 · Related supplement
Cementless Oxford Partial Knee System
P010014/S120 · Related supplement
Oxford Partial Knee System
Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P010014
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biomet Manufacturing Corp | PMA approval | Apr 21, 2004 | FDA | |
Cementless Oxford Partial Knee SystemP010014/S119 | Biomet Manufacturing Corp | PMA supplement | Oct 6, 2026 | FDA |
Oxford Partial Knee SystemP010014/S120 | Biomet Manufacturing Corp | PMA supplement | Oct 26, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biomet Manufacturing Corp
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P010014/S118
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

